Human B7-H2 / ICOSLG Protein, His Tag
分子別名(Synonym)
ICOSLG,B7-H2,B7H2,B7RP-1,B7RP1,CD275,GL50,ICOS-L,ICOSL,LICOS,ICOS ligand
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human B7-H2, His Tag (B72-H5221) is expressed from human 293 cells (HEK293). It contains AA Asp 19 - Ser 258 (Accession # NP_056074).
Predicted N-terminus: Asp 19
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 27.8 kDa. The protein migrates as 45-67 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
ICOS配體(ICOSLG)也稱為B7同源物2(B7-H2)、B7相關(guān)蛋白1(B7RP-1)和CD抗原CD275,屬于免疫球蛋白超家族和BTN/MOG家族。ICOSLG包含一個(gè)Ig-like C2型(免疫球蛋白樣)結(jié)構(gòu)域和一個(gè)Ig-like V型(免疫蛋白樣)功能域。異構(gòu)體1廣泛表達(dá),而異構(gòu)體2僅在淋巴結(jié)、白細(xì)胞和脾臟中檢測(cè)到。B7-H2是T細(xì)胞特異性細(xì)胞表面受體ICOS的配體。B7-H2作為T細(xì)胞增殖和細(xì)胞因子分泌的共刺激信號(hào),也誘導(dǎo)B細(xì)胞增殖和分化為漿細(xì)胞。B7-H2可能在介導(dǎo)局部組織對(duì)炎癥條件的反應(yīng)以及通過共刺激記憶T細(xì)胞功能調(diào)節(jié)二次免疫反應(yīng)中發(fā)揮重要作用。
關(guān)鍵字: B7-H2;B7-H2蛋白;B7-H2重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。